Please assess the completion status of the following clinical trial:

Trial Title: Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient with clinically defined multiple sclerosis~* All patients must be able to complete two trials of a timed 25 foot walk~Exclusion Criteria:~* Female patients who are either pregnant or breastfeeding.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo control
- Fampridine-SR (Type: ACTIVE_COMPARATOR): 10 mg b.i.d.

Based on this trial design, predict the completion outcome and termination type (if applicable).